The development of nontoxic natural agents with chemopreventive activity against colon cancer is the focus of investigation in many laboratories. Curcumin (feruylmethane), a natural plant product, possesses such chemopreventive activity, but the mechanisms by which it prevents cancer growth are not well understood. In the present study, we examined the mechanisms by which curcumin treatment affects the growth of colon cancer cells in vitro. Results showed that curcumin treatment causes p53-and p21-independent G 2 /M phase arrest and apoptosis in HCT-116(p53 +/+ ), HCT-116(p53 7/7 ) and HCT-116(p21 7/7 ) cell lines. We further investigated the association of the b-catenin-mediated c-Myc expression and the cell -cell adhesion pathways in curcumin-induced G 2 /M arrest and apoptosis in HCT-116 cells. Results described a caspase-3-mediated cleavage of b-catenin, decreased transactivation of b-catenin/Tcf-Lef, decreased promoter DNA binding activity of the bcatenin/Tcf-Lef complex, and decreased levels of c-Myc protein. These activities were linked with decreased Cdc2/cyclin B1 kinase activity, a function of the G 2 /M phase arrest. The decreased transactivation of b-catenin in curcumin-treated HCT-116 cells was unpreventable by caspase-3 inhibitor Z-DEVD-fmk, even though the curcumin-induced cleavage of b-catenin was blocked in Z-DEVD-fmk pretreated cells. The curcumin treatment also induced caspase-3-mediated degradation of cell -cell adhesion proteins b-catenin, E-cadherin and APC, which were linked with apoptosis, and this degradation was prevented with the caspase-3 inhibitor. Our results suggest that curcumin treatment impairs both Wnt signaling and cell -cell adhesion pathways, resulting in G 2 /M phase arrest and apoptosis in HCT-116 cells.
The development of nontoxic natural agents with chemopreventive activity against colon cancer is the focus of investigation in many laboratories. Curcumin (feruylmethane), a natural plant product, possesses such chemopreventive activity, but the mechanisms by which it prevents cancer growth are not well understood. In the present study, we examined the mechanisms by which curcumin treatment affects the growth of colon cancer cells in vitro. Results showed that curcumin treatment causes p53-and p21-independent G 2 /M phase arrest and apoptosis in HCT-116(p53 +/+ ), 7/7 ) and HCT-116(p21 7/7 ) cell lines. We further investigated the association of the b-catenin-mediated c-Myc expression and the cell -cell adhesion pathways in curcumin-induced G 2 /M arrest and apoptosis in HCT-116 cells. Results described a caspase-3-mediated cleavage of b-catenin, decreased transactivation of b-catenin/Tcf-Lef, decreased promoter DNA binding activity of the bcatenin/Tcf-Lef complex, and decreased levels of c-Myc protein. These activities were linked with decreased Cdc2/cyclin B1 kinase activity, a function of the G 2 /M phase arrest. The decreased transactivation of b-catenin in curcumin-treated HCT-116 cells was unpreventable by caspase-3 inhibitor Z-DEVD-fmk, even though the curcumin-induced cleavage of b-catenin was blocked in Z-DEVD-fmk pretreated cells. The curcumin treatment also induced caspase-3-mediated degradation of cell -cell adhesion proteins b-catenin, E-cadherin and APC, which were linked with apoptosis, and this degradation was prevented with the caspase-3 inhibitor. Our results suggest that curcumin treatment impairs both Wnt signaling and cell -cell adhesion pathways, resulting inIntroduction Dysregulation of the Wingless/Wnt (Wnt) signaling pathway is believed to play an important role in the pathogenesis of colorectal cancer (Polakis, 2000) . In a simple model, Wnt signaling regulates the assembly of a complex consisting of Axin (and its homolog Axil and conductin), adenomatous polyposis coli (APC), bcatenin, and glycogen synthase-3b kinase (GSK3b). Axin binds to APC, b-catenin, and GSK3b and thereby promotes b-catenin phosphorylation and subsequent ubiquitination and degradation in the proteasome. GSK3b regulates this process by phosphorylating components of the complex (Fearnhead et al., 2001; Huelsken and Birchmeier, 2001 ). Activation of the Wnt signaling pathway inhibits GSK3b and stabilizes bcatenin. Stabilizing mutations in b-catenin or truncation in APC also occurs both in colon cancer and melanoma cells and increases the stability of b-catenin. The stabilized pool of b-catenin associates with the members of the T-cell factor (Tcf)-lymphoid enhancer factor (Lef) family of transcription factors. There are four known members of the Tcf-Lef family in mammals. The human Tcf4 gene is specifically expressed in colon cancer cells (Korinek et al., 1997) . The b-catenin/Tcf4 complex is imported into the nucleus, where it binds to the Tcf-Lef consensus binding site, bends DNA to alter the local promoter environment, and changes the transcriptional activity of specific genes (Goss and Groden, 2000) . The bcatenin/Tcf-Lef complex regulates proto-oncogene and cell cycle regulator c-myc; the G 1 /S-regulating cyclin D1; the gene encoding the matrix-degrading metalloproteinase, matrysin; the AP-1 transcription factors cjun and fra-1; and the urokinase-type plasminogen activator receptor (Mann et al., 1999) . The mechanism by which these transcriptional changes contribute to early-stage colorectal carcinogenesis is still ambiguous.
In addition to its function in gene regulation, bcatenin also participates in cell -cell adhesion via interactions with the members of the cadherin family of proteins (Gumbiner, 2000; Polakis, 2000) . The Cterminal domain of E-cadherin is shown to interact with b-and g-catenin, which associate with a-catenin and form an E-cadherin complex with actin cytoskeleton. This complex maintains the stable cell -cell adhesion (Gumbiner, 2000) . APC is also a part of the cell -cell adhesion complex linked with E-cadherin, since it directly binds with b-catenin, g-catenin, and actin filament (Ben-Ze'ev and Geiger, 1998; Polakis, 2000) . In cells, in addition to its association with Wnt signaling and cell -cell adhesion complexes, b-catenin also exists as a free pool in the cytosol (Papkoff, 1997) . Thus, the dynamic distribution of b-catenin in different pools may determine its role in different cellular functions.
Dislodging cell -cell contacts and morphological changes involving imbalance in the cell -cell adhesion complex is one of the features of the apoptotic cells (Pawlak and Helfman, 2001 ). Recent reports have described the proteolytic cleavage of b-catenin, gcatenin, APC, and E-cadherin during drug-induced apoptosis of cancer cells (Brancolini et al., 1998; Ling et al., 2001; Schmeiser and Grand, 1999; Steinhusen et al., 2001) . It has been shown that disruption of the bcatenin binding site in the E-cadherin cytoplasmic tail abolishes stable cell -cell adhesion, whereas a direct association of E-cadherin to a-catenin does not facilitate cell -cell adhesion (Yap et al., 1997) . Reports describing drug-induced survival of Rat-1 cells after b-catenin/TcfLef transactivation supporting the role of decreased bcatenin signaling in apoptosis (Chen et al., 2001) . Furthermore, it is also reported that overexpression of b-catenin induces apoptosis independent of the transactivation activity and does not involve cell cycle regulators such as p53, Rb, cyclin D1 or E2F (Kim et al., 2000) . Thus, depending on the cell type or the stimulus received, these studies indicate that both cleavage and overexpression of b-catenin can be involved in apoptosis or survival of the cancer cells. Recently, b-catenin has been suggested as an important target for drug design for preventing growth and metastasis of cancer cells through multiple pathways including Wnt signaling and cell -cell adhesion (Daniels et al., 2001) .
Among the current treatment strategies, chemoprevention has received considerable promise as an effective approach for colon cancer prevention and is a focus of our current research efforts. Chemoprevention is the attempt to use dietary factors, synthetic pharmacological agents, and changes in lifestyle to intervene at the precancerous stages of carcinogenesis before the invasive disease commences (Kelloff et al., 1994) . The widely investigated chemopreventive agents include micronutrients, phytochemicals and synthetic pharmacological compounds (McCarty, 2001) . The phytochemical curcumin, or diferuylmethane [1,7-bis-(4-hydroxy-3-methoxypheny)-1,6-heptadiene-3,5-dione], is a major active component of turmeric and a member of the ginger family Curcuma longa (Zingiberacae). Of particular interest is the ability of curcumin to interfere with colon carcinogenesis in chemical and genetic rodent models (Kawamori et al., 1999; Mahmoud et al., 2000; Rao et al., 1995) . Dietary curcumin has shown to prevent cancer in the skin, forestomach, duodenum, tongue, mammary glands and sebaceous glands of mice and rats (Kelloff et al., 1996) . Furthermore, curcumin has been associated with the regression of established malignancy in humans (Kuttan et al., 1987; Sharma et al., 2001) . It also possesses anti-inflammatory properties and specifically inhibits cyclo-oxygenase-2 (COX-2) expression, which plays an important role in colon carcinogenesis (Goel et al., 2001) . Curcumin and some other polyphenols, including resveratrol, tannic acid, and gallic acid, induce apoptotic cell death in various cancer cell lines but not in normal cells (Ahmad et al., 1997; Clement et al., 1998; Inoue et al., 1994) . Curcumin induces apoptosis in melanoma cells through Fas receptor/ caspase-8 (Bush et al., 2001) . In prostate cancer cells, curcumin treatment down-regulates cell-survival mechanisms through caspase-3 and caspase-8 pathways (Mukhopadhyay et al., 2001) . The p53-dependent apoptosis induced by curcumin is also reported through p21 Waf1/Cip1 (hereafter p21) and GADD45 (Jee et al., 1998) . On the other hand, in human basalcell carcinoma cells, curcumin-induced apoptosis is independent of p53 (Jiang et al., 1996) . Curcumin also has a profound ability to block the NF-kB cell-survival pathway (Singh and Aggarwal, 1995) and protect skin cells from oxidative damage in vitro (Phan et al., 2001) . From these studies, it implied that curcumin treatment induces apoptosis and decreases cell growth in a wide range of cell types. However, it is unclear whether curcumin-induced Wnt signaling and/or cell -cell adhesion pathways play a role in growth arrest and apoptosis of colon cancer cells. In the present study, we have shown that curcumin treatment induces caspase-3-mediated b-catenin cleavage and c-Myc downregulation in the Wnt signaling pathway, resulting in G 2 /M phase arrest. We also found that the curcumin treatment induces apoptosis by increasing the degradation of b-catenin, E-cadherin, and APC and thus altering the cell -cell adhesion pathway.
Results

Curcumin-induced G 2 /M phase arrest and apoptosis of HCT-116 cells are p53-independent
Previous studies have demonstrated that curcumin induces growth arrest and apoptosis in p53-dependent and -independent pathways (Jee et al., 1998; Jiang et al., 1996) . In these studies, the p53-dependent andindependent studies were carried out in different cell types with different genetic backgrounds; therefore, the conclusion drawn from these studies cannot be generalized. Furthermore, the question of whether the p53 pathway is required for curcumin-induced growth arrest and apoptosis of colon cancer cells is currently less studied. To accommodate these concerns, this study examines the role of p53 and its downstream target gene, p21, in curcumin-induced growth arrest and apoptosis of colon cancer cell lines. The experiments were performed with the HCT-116 human colon cancer cell line, which carries the wild-type p53 and p21 genes. We refer to this cell line as HCT-116(p53 +/+ ). Two isogenic clones were derived from the HCT-116(p53 +/+ ) cell line by targeted deletion of p53 and p21 genes (Bunz et al., 1999) . We refer to these as active caspase-3 levels were determined with two different antibodies as described in Materials and methods. Activation of caspase-3 was determined by the decreased level of pro-caspase-3 (32 kDa) and by the increased level of active caspase-3 (17 and 19 kDa), which is generated by the cleavage of the pro-caspase-3 (Figure 2A,B) . The activation of caspase-3 was observed in all three cell lines. Since the functional activity of b-catenin is linked with its cleavage by caspase-3 (Brancolini et al., 1998; Chen et al., 2001; Ling et al., 2001; Schmeiser and Grand, 1999; Steinhusen et al., 2001; Yap et al., 1997) , we determined the level of b-catenin after curcumin treatment. The proteolytic cleavage products of bcatenin (in the range of 60 to 80 kDa) accumulated in all the cell lines that correlated with the activation of caspase-3 ( Figure 2C ). Next, we examined the level of c-Myc, an end product of the Wnt signaling pathway that is regulated by b-catenin/Tcf-Lef transactivation. In earlier studies, the dysregulation of c-myc gene expression has been associated with the development of colon cancer (He et al., 1998) , and the down-regulation has been linked with salicylate (an anti-inflammatory drug)-induced growth arrest of colon cancer cells (Law et al., 2000) . In our studies, after curcumin treatment, c-Myc protein level decreased in a time-dependent manner in all the cell lines, and this decrease was correlated with caspase-3 activation and b-catenin degradation ( Figure 2C ,D). To determine whether the decreased pro-caspase-3 and c-Myc protein levels in these experiments resulted from the curcumin treatment rather than the decreased loading of proteins in these lanes, we determined the level of a-tubulin, a constitutively expressed cellular protein. We found the level of a-tubulin unchanged in all of the three cell lines treated with curcumin ( Figure 2E ). These results suggest that curcumin treatment results in caspase-3 activation, b-catenin degradation, and c-Myc downregulation in a p53-and p21-independent manner that may involve the Wnt signaling pathway.
To directly test whether decreased c-Myc protein level was associated with the decreased c-myc gene expression, we determined reporter gene activity in HCT-116 cell lines treated with curcumin. It has been well established that c-myc gene's promoter contains a consensus b-catenin/Tcf-Lef response element, which regulates c-myc gene expression (Korinek et al., 1997 ). An earlier study describes a c-myc gene reporter construct with a consensus b-catenin/Tcf-Lef response element (Korinek et al., 1997) . This reporter construct is called the pTOP-FLASH for the wild-type and the pFOP-FLASH for the mutant (control) gene expression. We took the advantage of this assay system in our studies. If degraded b-catenin results in decreased levels of c-Myc by down-regulating c-myc gene expression, then, after curcumin treatment, we should find a pTOP-FLASH reporter activity decreased versus pFOP-FLASH reporter activity. Results showed a decrease in the pTOP-FLASH reporter activity in all the cell lines treated with 20 mM curcumin for 30 h ( Figure 3) . However, the extent of down-regulation of pTOP-FLASH reporter activity was much higher in the HCT-116(p21 7/7 ) cells than in HCT-116(p53 +/+ ) and HCT-116(p53 7/7 ) cells. A same level of inhibition in the pTOP-FLASH reporter activity as in the HCT-116(p21 7/7 ) cells was achieved when the HCT-116(p53 +/+ ) cells were treated with 20 mM curcumin for 45 h (data not shown). The pFOP-FLASH activity, a mutant for b-catenin/Tcf-Lef-binding, remained unchanged after curcumin treatment. This proposes that the functional binding of b-catenin/Tcf-Lef may be important for the pTOP-FLASH reporter activity. From these results, we conclude that the decreased level of c-Myc protein is a consequence of the decreased transcriptional activity of the b-catenin/TcfLef complex in curcumin-treated cells.
Z-DEVD-fmk blocks curcumin-induced cleavage of b-catenin but does not prevent b-catenin's transcriptional activity in HCT-116(p53 +/+ ) cells
To further examine the curcumin-induced caspase-3-mediated cleavage of b-catenin, we used the cell- Figure  4A with the pretreatment of cells with Z-DEVD-fmk for 1 h before curcumin treatment, the activation of caspase-3 and the cleavage of b-catenin was blocked in the HCT-116(p53 +/+ ) cell line. A similar result was observed in HCT-116(p53 7/7 ) and HCT-116(p21 7/7 ) cell lines (data not shown). Since the effect of curcumin treatment was identical in the parental and cloned HCT-116 cell lines, we used only the HCT-116 (p53 +/+ ) parental cell line in these experiments. Pretreatment of cells with Z-DEVD-fmk alone had no effect either on the caspase-3 activation or on the b-catenin degradation. To confirm that curcumin-induced cleavage of bcatenin occurs through a caspase-dependent pathway and to eliminate the possibility that it occurs through proteasome, calpain II, or lysosomal pathways, we pretreated the HCT-116(p53 +/+ ) cell line with proteasome inhibitor N-acetyl-leucyl-norleucinal (ALLn), calpain II inhibitor N-acetyl-leucyl-leucyl-methional (ALLm), and lysosomal inhibitors 3-methyladenine (3-MA) and leupeptin. Results shown in Figure 4B ,C clearly indicate that the curcumin-induced cleavage of b-catenin is not blocked by these inhibitors. This suggests that a caspase-3-dependent pathway is primarily responsible for curcumin-induced cleavage of b-catenin in HCT-116 cells.
On the basis of the above results, we hypothesized that maintaining the level of b-catenin by pretreatment with Z-DEVD-fmk would also maintain the b-catenin/Tcf-Lef transcriptional activity and hence the c-Myc level in the curcumin-treated HCT-116 cells. To test this idea, we transfected the HCT-116(p53 +/+ ) and HCT-116(p21 7/7 ) cell lines with either the pTOP-FLASH or the pFOP-FLASH plasmids, pretreated them with Z-DEVD-fmk, and then treated with 20 mM curcumin for 30 h. An unexpected event occurred; we found that the pretreatment with Z-DEVD-fmk was unable to block the curcumin-induced decrease in the pTOP-FLASH reporter activity ( Figure 5A ). However, since our hypothesis was based on the Z-DEVDfmk-mediated blockage of b-catenin cleavage in the curcumin-treated cells, it did not explain whether the functional activity of the b-catenin is also maintained in cells pretreated with Z-DEVD-fmk. Thus, to correlate the functional activity of b-catenin with the transcriptional regulation of the pTOP-FLASH reporter gene, we determined the interaction of the b-catenin/Tcf-Lef complex at the b-catenin/Tcf-Lef binding site on the pTOP-FLASH reporter DNA. For this purpose, an EMSA was set up with the HCT-116(p53 +/+ ) cell extract and 32 P-labeled nucleotide sequence, which is a consensus for the b-catenin/Tcf-Lef-binding and is the same as in the pTOP-FLASH and the c-myc promoters. The 32 Plabeled mutant oligonucleotide sequence, similar to the pFOP-FLASH reporter gene sequence, was used as a control. The nucleotide sequences used in these assays are given in Materials and methods (Korinek et al., 1997) Figure 5C ). From these results, we conclude that the transactivation of b-catenin is unpreventably altered in curcumin-treated HCT-116 cells, which is independent of caspase-3 activation. ) and HCT-116(p21
) cells. After 20 h of transfection, cells were treated with 20 mM curcumin for additional 30 h. Cells were harvested and processed for determining the luciferase gene-reporter activity. Data were normalized to bgal activity in the same experiment and are the mean+s.e. of three experiments Curcumin-induced G 2 /M phase arrest is associated with c-Myc down-regulation and Cdc2/cyclin B1 kinase inactivation, which is unchanged by Z-DEVD-fmk pretreatment
Since the dysregulation of c-Myc is associated with cellular proliferation, c-Myc down-regulation may be linked with the growth arrest of cancer cells. A recent study reports that in melanoma chemotherapy in vitro and in nude mice, use of a c-myc antisense genetherapy approach that induces G 2 /M phase arrest and apoptosis enhances the efficacy of cisplatin (Citro et al., 1998) . In the present study, we postulated that curcumin treatment would have a similar effect on the G 2 /M phase arrest and apoptosis of HCT-116 cells (Figure 1) . We pretreated HCT-116(p53 +/+ ) cells with Z-DEVD-fmk for 1 h before the treatment with curcumin. After 30 h, cells were processed for determining the cell cycle profile by FACS analysis. We found two interesting results in these experiments. First, the pretreatment of cells with Z-DEVD-fmk had no effect on curcumin-induced G 2 /M phase arrest of HCT-116(p53 +/+ ) cell line. Second, the curcumininduced apoptosis was blocked in the HCT-116(p53 +/+ ) cell line pretreated with Z-DEVD-fmk ( Figure 6A ). The lack of effect of Z-DEVD-fmk pretreatment on the G 2 /M phase arrest correlated with its lack of effect on the b-catenin transactivation and c-Myc down-regulation ( Figure 5) . Thus, the effect of curcumin treatment on apoptosis in the HCT-116 cell line is dissociated from the b-catenin transactivation pathway but linked with caspase-3 activity.
We further investigated the curcumin-induced G 2 /M phase arrest of the HCT-116(p53 +/+ ) cell line and the role of Z-DEVD-fmk by determining the Cdc2/cyclin B1 kinase activity, which is a marker for the G 2 /M phase arrest. The Cdc2/cyclin B1 kinase is inactivated in G 2 /M phase-arrested cells after phosphorylation at the Serine-14 and tyrosine-15 residues of the Cdc2 protein (O'Connell et al., 2000) . The results of our experiments showed that the phosphorylated level of Cdc2 and the level of cyclin B1 increased in curcumintreated cells but were unaffected in cells pretreated with Z-DEVD-fmk ( Figure 6B , subset a and b, compare lane 3 with 4). The slow-mobility bands, indicated as the phosphorylated forms of Cdc2, were independently confirmed with the anti-phospho-Cdc2(Y-15) antibody (data not shown). We further determined whether the increased levels of phosphorylated Cdc2 and the levels of cyclin B1 were associated with decreased kinase activity. The Cdc2/cyclin B1 complex was immunoprecipitated with anti-Cdc2 antibody and the histone H1 phosphorylation was determined. Results shown in Figure 6B (subset c) indicate that the Cdc2/cyclin B1 kinase activity is unaffected in curcumin-treated HCT-116(p53 +/+ ) cells. Pretreatment of these cells with Z-DEVD-fmk did not change the curcumin effect on the Cdc2/cyclin B1 kinase activity ( Figure 6B Curcumin treatment induces poly(ADP-ribose) polymerase-1 (PARP-1) cleavage and DNA degradation (TUNEL enzymatic-labeling) in apoptotic HCT-116 cells, which is blocked by Z-DEVD-fmk pretreatment
The FACS analysis results shown in Figures 1 and 6A indicate that curcumin treatment induces apoptosis in HCT-116(p53 +/+ ), HCT-116(p53 7/7 ) and HCT-116(p21 7/7 ) cell lines that is linked with caspase-3 activation. To further establish that curcumin treatment induces apoptosis in HCT-116 cells in which the activation of caspase-3 plays a role, we used two different methods -the PARP-1 cleavage and the terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) assay. PARP-1 cleavage is one of the well-accepted markers for the activation of downstream signals during early stages of apoptosis (Tewari et al., 1995) . PARP-1 is a substrate for caspase-3 and -7 that cleave it into 89 and 24 kDa fragments (Soldani and Scovassi, 2002) . Detection of the 89 kDa PARP-1 fragment with anti-PARP-1 antibody (and full-length 115 kDa PARP-1) thus serves as an early marker of apoptosis. In the present study, the cleavage of PARP-1 in HCT-116(p53 +/+ ), HCT-116(p53 7/7 ) and HCT-116(p21 7/7 ) cell lines after curcumin treatment was determined by Western blotting. To further determine whether curcumininduced cleavage of PARP-1 was mediated by caspase-3, cells were pretreated with Z-DEVD-fmk before curcumin treatment as described in the above experiments. We found 89 kDa fragment of PARP-1 in all the cell lines treated with 20 mM curcumin for 30 h, which was blocked by Z-DEVD-fmk pretreatment ( Figure 7A ). The PARP-1 cleavage in HCT-116(p53 +/ + ) and HCT-116(p53 7/7 ) after 30 h of curcumin treatment was less than HCT-116(p21 7/7 ) cells (compare lane 1 with 2, 5 with 6 and 9 with 10, respectively), which is consistent with the cleavage of bcatenin (Figure 2 ). These results suggest that HCT-116(p21 7/7 ) is more sensitive than HCT-116(p53 +/+ ) and HCT-116(p53 7/7 ) cells to curcumin treatment. To further confirm that apoptosis was induced by curcumin, we used TUNEL assay in these studies. TUNEL assay is frequently used to determine the excessive DNA fragmentation as a characteristic of early stages of apoptosis (Heatwole, 1999) . As shown in Figure 7B , the untreated (control) and Z-DEVDfmk pretreated HCT-116(p53 +/+ ) cells were unstained with TUNEL. On the other hand, curcumin treatment resulted in a significant number of TUNEL-positive 
Curcumin-induced degradation of cell -cell adhesion molecules b-catenin, E-cadherin and APC is blocked by Z-DEVD-fmk that is associated with apoptosis in HCT-116 cells
Results discussed above indicated that curcumininduced cleavage of b-catenin and apoptosis was blocked in HCT-p116(p53 +/+ ), HCT-116(p53 7/7 ) and HCT-116(p21 7/7 ) cell lines pretreated with Z-DEVDfmk. These events were independent of the b-catenin/ Tcf-Lef transactivation. Our next approach was to examine whether the cell -cell adhesion properties were altered by curcumin treatment that caused caspase-3-mediated apoptosis in these cell lines. To this end, we determined the levels of E-cadherin and APC, which, along with b-, g-and a-catenin, form an integral component of the cell -cell adhesion complex (Yap et al., 1997) . In these studies, we used HCT-116(p53 +/+ ) cells to determine the effect of curcumin treatment on cell -cell adhesion molecules. Results showed that the levels of b-catenin (Figures 2 and 4) , E-cadherin, and APC decreased in curcumin-treated HCT-116(p53 +/+ ) cells ( Figure 8A,B) . The decreased levels of these proteins were blocked in cells pretreated with Z-DEVD-fmk. We expected to observe the accumulation of the curcumin-induced E-cadherin and APC degradation products on the Western blots, but we failed to see this occur. Even when we ran a higher percentage of SDS -PAGE to determine the degradation products of APC, once again, we did not find an accumulation of such products (data not shown). Nonetheless, decreases in levels of both E-cadherin and APC were blocked in Z-DEVD-fmk pretreated cells, suggesting that caspase-3 might have a role in this process at the transcriptional steps of the E-cadherin and APC genes. From these results, we conclude that Z-DEVD-fmk-mediated blockage of curcumin-induced apoptosis is a result of the restoration of the cell -cell adhesion activity in the HCT-116(p53 +/+ ) cells that involves b-catenin, Ecadherin, and APC.
Discussion
Curcumin-induced growth arrest and apoptosis in HCT-116 cells are independent of p53
In the past, several studies reported the role of curcumin in growth arrest of cancer cells in culture and animal models (Huang et al., 1997; Manson et al., 2000; Pereira, 1999; Wargovich, 1997) . Those studies have implicated both p53-dependent and -independent pathways in curcumin-induced growth arrest; most often in the G 2 /M phase arrest of the cell cycle and apoptosis. Initially, our effort was to examine whether a p53-dependent pathway is critical for curcumininduced growth arrest and apoptosis of colon cancer cells. It is known that for sustained G 2 /M phase arrest to occur, it is important that there be p53-dependent induction of p21 and 14-3-3s proteins that normally sequester Cdc2/cyclin B1 complexes in the cytoplasm. A cooperative effect of p21 and 14-3-3s proteins has been shown in controlling the G 2 /M phase arrest of the HCT-116 cells treated with DNA-damaging agents (Chan et al., 2000) . Using isogenic HCT-116 cell lines with wild-type, p53 or p21 gene-knockout clones, we demonstrated that p53 and p21 induction is not necessary for curcumin-induced G 2 /M phase arrest and apoptosis of HCT-116 cells. This result may be due to the functional consequence of 14-3-3s, which is present in all the isogenic HCT-116 clones and may have been activated after curcumin treatment. However, after prolonged treatment with curcumin (30 h or more), we found that the HCT-116(p21 7/7 ) cell lines were more sensitive to cell death than the HCT-116(p53 7/7 ) or the HCT-116(p53 +/+ ) cell lines (data not shown). In earlier studies, the anticancer efficacy of g-irradiation has been found more effective in vivo on growth of HCT-116(p21 7/7 ) than on growth of HCT-116(p53 +/+ ) cells, suggesting that the p21-checkpoint-deficient cells are hypersensitive to cell death (Waldman et al., 1997) . Furthermore, mutations in p21 or 14-3-3s genes may not have a serious effect on the control of cell cycle, as the mutation of the p53 gene is required to reduce the expression of these two genes. Our results indicate that curcumin treatment can induce G 2 /M phase arrest and apoptosis in both p53 and p21 gene-knockout cell lines; thus it may have broader chemopreventive efficacy for colon cancers.
Curcumin treatment affects b-catenin/Tcf-Lef transactivation resulting in G 2 /M phase arrest of HCT-116 cells Growth of epithelial and endothelial cells is strictly anchorage-dependent with strong cell -matrix and cell -cell contacts (Frisch and Francis, 1994; Meredith et al., 1993; Re et al., 1994) . The family of caspases plays a major role during the execution of apoptosis (Thornberry and Lazebnik, 1998) . The main function of caspases is to activate down-stream caspases and executor caspases, which are responsible for dismantling cellular proteins. Two distinct pathways -one included by receptor-mediated signaling at the plasma membrane and the other triggered by the leakage of cytochrome c (Cyt c) from mitochondria -lead to caspase activation. The death receptor pathway initially activates pro-caspase-8, whereas, the mitochondrial pathway initially involves pro-caspase-9. It is reported that the activation of caspase-9 by DNAdamaging agents (Schuler and Green, 2001 ) and of caspase-8 by curcumin (Bush et al., 2001) leads to cell death. In both cases, a decrease in mitochondrial transmembrane potential, release of Cyt c into the cytosol, and cleavage of pro-caspase-9 or -8 to its active form preceded the activation of caspase-3. Our hypothesis was that curcumin treatment enhances caspase-3 activity, leading to the cleavage of b-catenin and altering the b-catenin-mediated cellular functions of growth arrest and apoptosis. Apoptosis-induced cleavage of b-catenin by caspase-3 has been reported earlier (Steinhusen et al., 2000) . b-catenin is implicated in signal transduction, regulation of gene expression, and cell -cell adhesion. Thus, b-catenin provides a molecular mechanism for the transmission of signals from cell -cell adhesion components to the nucleus (Polakis, 200; Huelsken and Birchmeier, 2001) .
The transactivation property of b-catenin is regulated by the Wnt signaling pathway, which is critical in the development of colorectal cancer (Fearnhead et al., 2001; Huelsken and Birchmeier, 2001; Polakis, 2000) . In this pathway, APC negatively regulates the level of b-catenin by facilitating GSK3b-mediated phosphorylation and then proteasome-mediated degradation. In the cells, a mutation in either the APC or the b-catenin gene in the critical phosphorylation region which is involved in proteasome-mediated degradation, stabilizes b-catenin level. In HCT-116 cells, the b-catenin levels are not regulated by APC because of its mutations in the phosphorylation and ubiquitination region of the b-catenin protein (Ilyas et al., 1997) . Thus, b-catenin is functional in the HCT-116 cell line and after forming a complex with Tcf/Lef transcription factor in the nucleus, it regulates the expression of bcatenin/Tcf-Lef target genes. Two Wnt signaling target genes were considered important in this study: cyclin D1 and c-myc. Because curcumin treatment caused a G 2 /M arrest in HCT-116 cells, our focus was toward cMyc, since c-Myc has been implicated in G 2 /M phase arrest (Obaya et al., 1999) . We found a caspase-3-mediated cleavage of b-catenin in curcumin-treated HCT-116 cells resulting in decreased formation of the DNA*b-catenin/Tcf-Lef complex, which transcriptionally down-regulated the pTOP-FLASH reporter activity, and hence, decreased c-Myc protein levels. It is interesting to note that although b-catenin cleavage was blocked in cells pretreated with Z-DEVD-fmk, the functional activity of the b-catenin/Tcf-Lef complex was not blocked. This could be due to several reasons. It is possible that the level of Tcf-Lef was unpreventably modified by curcumin treatment and that the level was independent of the caspase-3 activity, since bcatenin requires binding with Tcf/Lef for its transcriptional activity. Another reason could be the curcumininduced activation of Groucho/TLE and CtBP corepressors and the CREB-binding protein CBP, which are known to bind and repress the b-catenin/Tcf-Lefmediated gene expression (Polakis, 2000) . Our future studies will test these possibilities. In previous studies, using SW620 colon cancer cell line, Bordonaro et al. (1999) have suggested that curcumin treatment to this cell line did not modulate b-catenin/Tcf-Lef pathway and had minor or no effect on apoptosis. The discrepancy in our study and their report is perhaps due to following reasons: First, Bordonaro et al. (1999) used SW620 colon cancer cell line in their studies that expresses mutant APC level. Thus, any contribution of the wild-type APC in curcumin-mediated responses cannot be clearly discussed. Second, the important difference could be the time period of curcumin treatment to SW620 cell lines, which were restricted up to 16 to 24 h versus 30 h or more that is used in our studies. In congruence with their findings, up to 15 h treatment, we also found that curcumin did not modulate b-catenin/Tcf-Lef transactivation and had no effect on apoptosis in HCT-116 cell lines. This is consistent with the results obtained with SW620 cell line (Bordonaro et al., 1999) . Furthermore, we used three different assays to determine whether curcumin treatment induces apoptosis in HCT-116(p53 +/+ ), HCT-116(p53 7/7 ) and HCT-116(p21 7/7 ) cell lines. Our results with FACS analysis, PARP-1 cleavage, and TUNEL enzymatic-labeling of the fragmented DNA clearly indicate that curcumin treatment for 30 h resulted in apoptosis in HCT-116 cell lines. Our results are in agreement with recently published studies on curcumin induced cell cycle arrest and apoptosis in HCT-116(p53 +/+ ) cell line (Moragoda et al., 2001 ). The effect of curcumin treatment on the caspase-3-mediated b-catenin transactivation was unevitable, and thus, a decrease in levels of c-Myc was not blocked in HCT-116 cells pretreated with Z-DEVD-fmk. We believe that the decreased level of c-Myc is linked with the G 2 /M phase arrest in curcumin-treated HCT-116 cells. The findings of G 2 /M phase arrest in these cells was supported by the findings of increased phosphorylated and kinase inactive levels of Cdc2. Our findings of curcumin-induced c-Myc down-regulation and its association with G 2 /M phase arrest are similar to those reported for salicylate-mediated effects on c-Myc levels (Law et al., 2000) . How c-Myc causes G 2 /M phase arrest is still unclear. On the account of results, it is possible that c-Myc influences Cdc2/cyclin B1 activity in curcumin-treated HCT-116 cells. Another speculation might be that the c-Myc-mediated repression of p27 can cause prolonged G 2 /M phase arrest in these cells (Boxer and Dang, 2001) .
Curcumin treatment affects the cell -cell adhesion pathway to ensue apoptosis of HCT-116 cells Like the Wnt signaling pathway, b-catenin independently functions in the cell -cell adhesion pathway in association with E-cadherin, APC, and g-and a-catenin (Fearnhead et al., 2001; Huelsken and Birchmeier, 2001; Polakis, 2000) . The role of caspase-3-mediated cleavage of b-catenin in apoptosis has been established in earlier studies (Brancolini et al., 1998; Ling et al., 2001; Schmeiser and Grand, 1999; Steinhusen et al., 2001 ). Thus, a critical balance among the levels of these proteins is essential for maintaining the normal cellular communications and growth characteristics of the cells. Lack of expression of one or more of these components can cause disruption in cell -cell adhesion, resulting in apoptosis. We argue that the caspase-3-mediated degradation of b-catenin, E-cadherin, and APC is linked with the loss of cell -cell adhesion, which may result in apoptosis in curcumin-treated HCT-116 cells. Our result was further supported by caspase-3 inhibitor, which blocked the degradation of these molecules and prevented the effect of curcumin on apoptosis in the HCT-116 cells. In previous studies, the degradation of b-catenin (Brancolini et al., 1998; Ling et al., 2001 ), E-cadherin (Schmeiser and Grand, 1999; Steinhusen et al., 2001) , and APC (Browne et al., 1994 (Browne et al., , 1998 Ling et al., 2001 ) has been associated with apoptosis of cells. Thus, our results are consistent with those studies and suggest that curcumin treatment induces apoptosis in HCT-116 cells that is mediated through cell -cell adhesion pathway. Although the interpretation of the data on cell -cell adhesion are based on correlative results, in the future studies, we are planning to examine the role of APC, E-cadherin, and b-catenin in curcumin-induced cell -cell adhesion and apoptosis by manipulating the levels of these proteins in HCT-116 cells. To determine the protective effect of these proteins against curcumin-induced apoptosis, we will overexpress these proteins separately or in combination into the HCT-116 cells. To further determine that the decreased levels of APC, E-cadherin and b-catenin proteins may increase sensitivity of HCT-116 cells toward apoptosis after curcumin treatment, we will down-regulate the expression of APC, E-cadherin and b-catenin in these cells using oligonucleotide-based antisense RNA-or small interfering RNAs (siRNAs)-based techniques.
In summary, these studies provide a better understanding of the molecular mechanisms by which curcumin intervenes in different cellular pathways to induce cell cycle arrest and apoptosis in colon cancer cells. These findings are highly clinically significant, and in the future, curcumin may prove an important chemopreventive agent for colorectal and other types of cancers. Its usefulness in the chemoprevention of colon cancer can be further extended to patients developing colon cancer without mutations in the APC gene. Curcumin treatment decreases growth of colon cancer cells in the Apc(min) mice model that carries a mutant APC gene (Mahmoud et al., 2000) and in the HCT-116 cell line that carries a wild-type APC gene (present study). In the case of the Apc(min) or the Apc(D716) mice model, it is suggested that the decrease in growth of colon cancer cells occurs through the COX-2 pathway (Sonoshita et al., 2001; Williams et al., 1999) ; in the case of cells carrying the wild-type APC gene, colon cancer growth may decrease through the Wnt signaling and the cell -cell adhesion pathways (present study). An in vitro study has reported a specific inhibition of COX-2 in the HT-29 colon cancer cell line, which carries a mutant APC gene (Goel et al., 2001 ). Thus, curcumin can be a wide-spectrum chemopreventive agent for colon cancer treatment.
Materials and methods
Cell lines and treatment
Human colon cancer cell line HCT-116 with wild-type p53 gene (p53 +/+ ) or with p53 gene-knockout (p53 7/7 ) and p21 gene-knockout (p21 7/7 ) were grown in McCoy's 5a medium supplemented with 10% fetal bovine serum (FBS; HyClone) and 100 mg/ml of penicillin and streptomycin (GIBCO -BRL). Cells were grown at 378C under a humidified atmosphere of 5% carbon dioxide. After cell cultures were 70% confluent, they were treated with different concentrations of curcumin (Sigma Chem. Co.) for different periods as indicated in Figure legends .
FACS analysis
Cells were harvested from untreated and treated groups at indicated periods and processed for propidium iodide staining of nuclei for determining their distribution into different phases of the cell cycle as described previously Vindelov and Christensen, 1990) . The cellular DNA content was analysed by FACScan flow cytometer. The ranges for G 0 /G 1 , S, G 2 /M, and sub-G 1 phase cells were established on the basis of the corresponding DNA content of histograms. At least 10 000 cells per sample were considered in the gated regions used for calculations.
Western blot analysis
After treatment, cells were washed with cold phosphatebuffered saline containing 1 mM dithiothreitol (DTT) and 1 mM phenylmethylsulfonylfluoride (PMSF) and lysed as described previously (Narayan and Jaiswal, 1997) . For procaspase-3, and active caspase-3 levels, 50 mg of cell lysate was analysed on a 12.5% sodium dodecylsulfate (SDS)-polyacrylamide gel electrophoresis (PAGE). The APC protein level, the b-catenin and PARP-1 cleavage products and the c-Myc, E-cadherin and a-tubulin protein levels were determined on 4, 8 and 9% SDS -PAGEs, respectively. The proteins were electroblotted on an Immobilon-P membrane and probed with antibodies. The antibodies used were obtained from Cell Signaling Technology, Inc. (active caspase-3), BD Transduction Laboratories (pro-caspase-3), Oncogene Science (APC), Sigma-Aldrich Chem. Co. (a-tubulin), Santa Cruz Biotech., Inc. (b-catenin, E-cadherin, c-Myc) and UP State Biotechnology (PARP-1).
Gene regulation by transient transfection assay
Using Lipofectamine reagent (GIBCO -BRL, Bethesda, MD, USA), we transfected the parental and the cloned isogenic HCT-116 cell lines with reporter plasmids that had b-catenin/ Tcf-Lef-responsive (pTOP-FLASH) and mutant (pFOP-FLASH) promoters Korinek et al., 1997) . Briefly, cells were grown to 60% confluence in 60 mm tissue culture dishes and transfected with 1.0 mg/ml of the promoter constructs, 0.25 mg/ml of the pCMV-bgalactosidase (b-gal) plasmid, and 14 mg/ml of the Lipofectamine reagent. pCMV-b-gal served as an internal control to correct the differences in the transfection efficiency. DNAlipid complex was then added to the cells as per recommended protocol by the manufacturer. After 24 h of post transfection, cells were treated with 20 mM curcumin for 30 h. After the treatment, we prepared cellular lysates for luciferase-reporter activity using a Monolight TM 3010-Illuminometer (Pharmingen, San Diego, CA, USA).
Electrophoretic mobility gel-shift analysis (EMSA)
For EMSA, a double-stranded 15-nucleotide oligomer bcatenin/Tcf-Lef probe was used (Korinek et al., 1997) . The nucleotide sequence of the wild-type (5'-CCCTTTGATCT-TACC-3') and the mutant (5'-CCCTTTGGCCTTACC-3') oligomers were obtained from Sigma-Genosys (Woodlands, TX, USA). DNA*protein-binding reactions were carried out in 20 ml final volume containing 20 mM HEPES at pH 7.9, 1 mM DTT, 3.5 mM MgCl 2 , 100 mM KCl, 0.03% (v/v) Nonidet-P40, 10% (v/v) glycerol, 1 mg poly(dI.dC) and 5 mg of cell lysate. Reactions were carried out for 10 min at 228C, followed by the addition of 1 ng of g 32 P-labeled b-catenin/ Tcf-Lef-binding oligonucleotide of the c-myc promoter (Korinek et al., 1997) and the mixture was incubated further for 20 min at 228C. The entire reaction mixture was loaded directly onto a native 4% polyacrylmiade gel. After electrophoresis, the shifted DNA*protein complexes were visualized by autoradiography.
Histone H1 kinase assay
We performed immunoprecipitation of the Cdc2/cyclin B1 kinase complex, which is specific for histone H1 phosphorylation, with 150 mg of cell lysate using 2 mg of anti-Cdc2 antibody (Pines and Hunter, 1994) . Immunoprecipitated samples were pre-incubated with a buffer containing 12.5 mM HEPES at pH 7.5, 12.5 mM b-glycerophosphate, 7.5 mM MgCl 2 , 2 mM EGTA, 0.5 mM orthovanadate, 0.5 mM NaF, and 0.5 mM DTT for 5 min at 308C. The reaction was initiated with 10 mg histone H1 (UP State Biotech), 20 mM ATP and 1 mCi [g 32 P]ATP (3000 Ci/mmol). After 20 min incubation at 308C, the reaction was stopped by the addition of SDS -PAGE sample buffer and boiled for 5 min. The 32 Plabeled histone H1 was separated on a 12% SDS -PAGE, and the signal was detected by autoradiography.
TUNEL assay
The HCT-116(p53 +/+ ) cells were grown on cover-slips. The treatment schedule with Z-DEVD-fmk and curcumin was the same as described above. After treatment, cells were fixed with acetone, washed with phosphate-buffered Tris-HCl, pH 7.2, and processed for TUNEL enzymatic labeling using ApoTag 1 Peroxidase in situ apoptosis detection kit as described by the manufacturer (Intergen Co., Purchase, NY, USA). TUNEL-positive apoptotic cells (dark blue color) were visualized under the microscope (Leica, Germany, Model DMLB 100S) and photographed for permanent records.
